United States

Analyst Research Report Snapshot


Regenersis - Ticking all the boxes




Equity Development


18 Mar 2013





Companies referenced:


Available for Immediate Download

Regenersis is a provider of an integrated, brand support, outsourcing solution to product and service providers, has emerged strongly following an overhaul of strategy and a comprehensive reorganisation. Their impressive growth trajectory has been confirmed in the recent strong interim results, showing that financial performance is on track with double-digit organic revenue and profit growth, and that the growth strategy is succeeding, with the main focus on emerging markets and Advanced Solutions delivering results. Regenersis now has modest debt levels and good access to debt-finance. It has significant capacity to grow and invest, and the proven pedigree in M&A of the management team should mean an exciting future. Applying a 2014E EV / EBITDA multiple of 9.2x indicates a fair value share price of 247p, versus 196p today, and we expect to see deals and contract wins that will further improve prospects and forecasts.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.